Geode Capital Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.6M Buy
352,923
+4,306
+1% +$337K ﹤0.01% 1788
2025
Q1
$25.2M Buy
348,617
+5,585
+2% +$404K ﹤0.01% 1778
2024
Q4
$30.4M Sell
343,032
-41
-0% -$3.64K ﹤0.01% 1728
2024
Q3
$29M Buy
343,073
+4,477
+1% +$379K ﹤0.01% 1782
2024
Q2
$31.3M Buy
338,596
+11,346
+3% +$1.05M ﹤0.01% 1672
2024
Q1
$36.9M Buy
327,250
+12,892
+4% +$1.46M ﹤0.01% 1558
2023
Q4
$29.3M Buy
314,358
+17,417
+6% +$1.62M ﹤0.01% 1683
2023
Q3
$27.2M Buy
296,941
+29,166
+11% +$2.68M ﹤0.01% 1627
2023
Q2
$32.5M Buy
267,775
+27,720
+12% +$3.36M ﹤0.01% 1533
2023
Q1
$23.5M Sell
240,055
-13,747
-5% -$1.35M ﹤0.01% 1682
2022
Q4
$20.6M Sell
253,802
-284
-0.1% -$23K ﹤0.01% 1756
2022
Q3
$19.3M Buy
254,086
+6,958
+3% +$529K ﹤0.01% 1762
2022
Q2
$27M Buy
247,128
+18,205
+8% +$1.99M ﹤0.01% 1546
2022
Q1
$22.8M Buy
228,923
+10,128
+5% +$1.01M ﹤0.01% 1809
2021
Q4
$20.9M Buy
218,795
+1,951
+0.9% +$186K ﹤0.01% 1930
2021
Q3
$24M Buy
216,844
+1,647
+0.8% +$182K ﹤0.01% 1825
2021
Q2
$24.9M Buy
215,197
+7,175
+3% +$831K ﹤0.01% 1818
2021
Q1
$21.7M Buy
208,022
+18,819
+10% +$1.96M ﹤0.01% 1834
2020
Q4
$22.8M Buy
189,203
+64
+0% +$7.7K ﹤0.01% 1642
2020
Q3
$16.4M Sell
189,139
-671
-0.4% -$58.3K ﹤0.01% 1664
2020
Q2
$15.4M Buy
189,810
+3,626
+2% +$294K ﹤0.01% 1678
2020
Q1
$12.8M Buy
186,184
+9,436
+5% +$651K ﹤0.01% 1584
2019
Q4
$20.2M Buy
176,748
+2,633
+2% +$301K ﹤0.01% 1551
2019
Q3
$22.7M Buy
174,115
+1,519
+0.9% +$198K 0.01% 1393
2019
Q2
$21.2M Buy
172,596
+11,391
+7% +$1.4M 0.01% 1447
2019
Q1
$16.9M Buy
161,205
+14,538
+10% +$1.53M ﹤0.01% 1540
2018
Q4
$15M Buy
146,667
+15,556
+12% +$1.59M ﹤0.01% 1481
2018
Q3
$15.5M Buy
131,111
+15,337
+13% +$1.82M ﹤0.01% 1592
2018
Q2
$11.1M Buy
115,774
+10,661
+10% +$1.02M ﹤0.01% 1797
2018
Q1
$8.55M Buy
105,113
+2,123
+2% +$173K ﹤0.01% 1882
2017
Q4
$7.44M Buy
102,990
+3,699
+4% +$267K ﹤0.01% 1954
2017
Q3
$6.1M Buy
99,291
+5,445
+6% +$335K ﹤0.01% 2077
2017
Q2
$5.67M Buy
93,846
+2,537
+3% +$153K ﹤0.01% 2065
2017
Q1
$5.96M Buy
91,309
+5,130
+6% +$335K ﹤0.01% 1987
2016
Q4
$6.05M Buy
86,179
+2,166
+3% +$152K ﹤0.01% 1937
2016
Q3
$5.27M Buy
84,013
+879
+1% +$55.1K ﹤0.01% 1942
2016
Q2
$5.01M Buy
83,134
+3,966
+5% +$239K ﹤0.01% 1913
2016
Q1
$3.94K Buy
79,168
+4,435
+6% +$221 ﹤0.01% 2023
2015
Q4
$4.01M Buy
74,733
+567
+0.8% +$30.4K ﹤0.01% 2016
2015
Q3
$3.33M Buy
74,166
+831
+1% +$37.3K ﹤0.01% 2113
2015
Q2
$4.02M Buy
73,335
+595
+0.8% +$32.6K ﹤0.01% 2056
2015
Q1
$3.46M Buy
72,740
+11,795
+19% +$560K ﹤0.01% 2086
2014
Q4
$2.56M Buy
60,945
+608
+1% +$25.5K ﹤0.01% 2272
2014
Q3
$2.14M Buy
60,337
+47
+0.1% +$1.66K ﹤0.01% 2325
2014
Q2
$2.06M Buy
60,290
+489
+0.8% +$16.7K ﹤0.01% 2353
2014
Q1
$2.07M Buy
59,801
+4,738
+9% +$164K ﹤0.01% 2318
2013
Q4
$1.94M Buy
55,063
+4,483
+9% +$158K ﹤0.01% 2308
2013
Q3
$1.57M Buy
50,580
+200
+0.4% +$6.22K ﹤0.01% 2316
2013
Q2
$1.39M Buy
+50,380
New +$1.39M ﹤0.01% 2266